Literature DB >> 11891941

Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck.

David I Rosenthal1, Li Liu, Jason H Lee, Neha Vapiwala, Ara A Chalian, Gregory S Weinstein, Irina Chilian, Randal S Weber, Mitchell Machtay.   

Abstract

BACKGROUND: To determine the effect of treatment time-related factors on outcome in patients treated with surgery and postoperative radiation therapy (RT) for locally advanced squamous cell carcinoma of head and neck (SCCHN)
METHODS: A retrospective review was performed on 208 consecutive patients treated from 1992 to 1997 with surgery and postoperative RT (> or =55 Gy) for SCCHN. The treatment time factors considered were (1) interval from surgery to the start of RT; (2) RT duration; and (3) the total time from surgery to completion of RT (treatment package time). Treatment package time was dichotomized into short (< or =100 days) vs long (>100 days) categories. Other variables considered were clinical and pathologic staging, margin status, RT dose, and tumor site. Patients were also divided into intermediate- and high-risk groups on the basis of eligibility for RTOG 95-01. Univariate (logrank) and multivariate analyses were performed.
RESULTS: Median follow-up for surviving patients was 24 months. Actuarial 2-year locoregional control (LRC) and survival rates were 82% and 71%, respectively. In univariate analysis, factors associated with higher locoregional failure were high-risk group (p =.011), margin status (p =.038), pathologic stage (p =.035), clinical N stage (p =.006), package time (p =.013), and RT treatment time (p =.03). Package time was also a significant predictor of survival in univariate analysis (p =.021). The other two individual time factors, tumor factors, and RT dose were not significant. Both risk status and treatment package time were significant factors in a multivariate model of LRC.
CONCLUSIONS: A total treatment package time of <100 days is associated with improved tumor control and survival. Every effort should be made to keep the time from surgery to the completion of postoperative RT to <100 days. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11891941     DOI: 10.1002/hed.10038

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  36 in total

1.  Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.

Authors:  Young-Hoon Joo; Ie-Ryung Yoo; Kwang-Jae Cho; Jun-Ook Park; In-Chul Nam; Chung-Soo Kim; Min-Sik Kim
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-15       Impact factor: 2.503

2.  Saving time is saving lives: a delayed lobectomy predicts poorer overall survival in patients with clinical stage IA squamous cell carcinoma of the lung.

Authors:  Ching Feng Wu; Yin-Kai Chao
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

3.  A comparison of concurrent cisplatin versus cetuximab with radiotherapy in locally-advanced head and neck cancer: A bi-institutional analysis.

Authors:  William A Stokes; Whitney A Sumner; Kiersten L Breggren; John T Rathbun; David Raben; Jessica D McDermott; Gregory Gan; Sana D Karam
Journal:  Rep Pract Oncol Radiother       Date:  2017-08-02

4.  Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.

Authors:  Evan M Graboyes; Elizabeth Garrett-Mayer; Mark A Ellis; Anand K Sharma; Amy E Wahlquist; Eric J Lentsch; Brian Nussenbaum; Terry A Day
Journal:  Cancer       Date:  2017-08-25       Impact factor: 6.860

5.  Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma.

Authors:  Sonam Sharma; Justin Bekelman; Alexander Lin; J Nicholas Lukens; Benjamin R Roman; Nandita Mitra; Samuel Swisher-McClure
Journal:  Oral Oncol       Date:  2016-03-16       Impact factor: 5.337

Review 6.  Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Authors:  Muhammad M Fareed; Rizwan Ishtiaq; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2018-03-12

Review 7.  Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions.

Authors:  Steven B Chinn; Jeffrey N Myers
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

Review 8.  Perineural Spread in Noncutaneous Head and Neck Cancer: New Insights into an Old Problem.

Authors:  Moran Amit; Ayelet Eran; Salem Billan; Eran Fridman; Shorook Na'ara; Tomer Charas; Ziv Gil
Journal:  J Neurol Surg B Skull Base       Date:  2016-02-26

9.  Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer.

Authors:  Allen S Ho; Zachary S Zumsteg; Annika Meyer; Nadeem Riaz; Rahmatullah Rahmati; Dennis H Kraus; Colleen McCarthy; Richard J Wong; Jatin P Shah; Nancy Y Lee
Journal:  Ann Surg Oncol       Date:  2016-08-09       Impact factor: 5.344

10.  Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma.

Authors:  Pinaki R Dutta; Nadeem Riaz; Sean McBride; Luc G Morris; Snehal Patel; Ian Ganly; Richard J Wong; Frank Palmer; Heiko Schöder; Nancy Lee
Journal:  Head Neck       Date:  2015-09-03       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.